Posted by The journal Molecules (IF 4.411) started to collect manuscripts for special issue on ” Drug-Cyclodextrin Interactions. A Basis for New Formulations “.
The following discounts are provided for early bird submissions to this Special Issue:
Early Bird Discount before 31 October 2021: 30%
Early Bird Discount before 1 December 2021: 20%
Special Issue Editors
Prof. Dr. Thomas MavromoustakosE-MailWebsiteSciProfiles
Guest Editor
Department of Chemistry, National & Kapodistrian University of Athens, Athens, Greece
Interests: hypertension; structure elucidation; nuclear magnetic resonance; spectroscopy; NMR spectroscopy; medicinal and pharmaceutical chemistry; molecular modeling; Raman spectroscopy; DSC; NMR structure elucidation
Dr. Andreas TzakosE-MailWebsiteSciProfiles
Guest Editor
Department of Chemistry, University of Ioannina, Ioannina, Greece
Interests: development of tumor-homing and tumor-responsive drug delivery vehicles as theranostics; drug formulations and prodrugs; development of imaging agents for visualizing and charting cellular compartments; pharmacokinetics (LC-MS, HPLC-based) and bioactivity evaluation; design and development of cancer diagnostics and theranostics; development of tumor-homing probes equipped with multimodal imaging agents (for MRI, in vivo near-infrared I & II optical imaging, and SPECT/PET probes)
Prof. Dr. Georgia N. ValsamiE-MailWebsite
Guest Editor
Department of Pharmacy, National & Kapodistrian University of Athens, Athens, Greece
Interests: drug-protein binding; drug-cyclodextrins interaction, characterization and effect on drug solubility/dissolution/absorption; Development and in vitro-in vivo evaluation of novel dosage forms with optimized absorption (GI/nasal/pulmonary); PK/PD studies and dosage individualization
Read more: https://www.mdpi.com/journal/molecules/special_issues/drug_cyclodextrin
2 comments